A Clinical Study to Assess the Feasibility and Safety of Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer
Conditions: Non Metastatic Locally Recurrent Prostate Cancer Interventions: Device: Experimental: DaRT seeds Sponsors: Alpha Tau Medical LTD. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate Cancer
Conditions: PSMA Positive Metastatic Prostate Cancer Interventions: Radiation: [131I]/[18F]/[68Ga]ZT-111 Sponsors: Huashan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
Conditions: Localized Prostate Carcinoma Interventions: Radiation: High dose rate prostate brachytherapy Sponsors: British Columbia Cancer Agency; BC Cancer Foundation; University of British Columbia; Vancouver Prostate Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
ARON-3 Study: International Multicentric Retrospective Study to Collect Global Experiences in the Treatment of Patients With Metastatic PCa
Conditions: Prostate Cancer Sponsors: Hospital of Macerata Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Stereotactic Re-irradiation of Local Recurrences of Prostate Cancer After Radiotherapy
Conditions: Local Recurrence of Malignant Tumor of Prostate; Radiotherapy Interventions: Radiation: Stereotactic Body Radiotherapy Sponsors: Maria Sklodowska-Curie National Research Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
The Effect of 360 ° Virtual Reality Movies on Fear and Anxiety
Conditions: Fear; Anxiety; Breast Cancer; Lung Cancer; Prostate Cancer; Head and Neck Cancer; Brain Tumor Interventions: Other: Questionnaire: SPIRIT; Other: Questionnaire: HADS; Other: Questionnaire: QSC-R23; Other: General questions; Other: Clinical data collected Sponsors: Maastricht Radiation Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
Conditions: Prostate Cancer; Prostate Adenocarcinoma; Prostate Carcinoma Interventions: Radiation: Spot Delete planning for proton therapy; Radiation: Traditional proton treatment planning system Sponsors: Thompson Cancer Survival Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Conditions: Castration-Resistant Prostate Carcinoma; Stage IVB Prostate Cancer AJCC v8 Interventions: Procedure: Biospecimen Collection; Procedure: Bone Scan; Other: Clinical Observation; Procedure: Computed Tomography; Other: Gallium Ga 68 Gozetotide; Drug: Lutetium Lu 177 Vipivotide Tetraxetan; Procedure: Positron Emission Tomography; Other: Questionnaire Administration; Procedure: Single Photon Emission Computed Tomography Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Radiotherapy for Prostate and Oligo-metastatic Lesions in Patients With Low-burden Oligo-metastatic Prostate Cancer
Conditions: Oligo-metastatic Prostate Carcinoma Interventions: Radiation: hormone and RT; Drug: ADT combined with abiraterone Sponsors: Changhai Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
DeADT - Living Well With Prostate Cancer
Conditions: Prostate Cancer Interventions: Behavioral: ADT Order Check Attestation (Or); Behavioral: Provider Script (Sc) Sponsors: University of Michigan; US Department of Veterans Affairs; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Effect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer Patients
Conditions: Prostate Cancer; Metastatic Cancer; Hormone Sensitive Prostate Cancer; Castration-resistant Prostate Cancer Interventions: Drug: Abiraterone Acetate Sponsors: National University Hospital, Singapore; National University of Singapore Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
LTFU for All Cell and Gene Therapy Studies
Conditions: Hepatocellular Carcinoma; Prostate Cancer Interventions: Biological: AZD5851 Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC
Conditions: Metastatic Castration-resistant Prostate Cancer Interventions: Biological: MSGV1-PSCA-8T28Z; Drug: Fludarabine; Drug: Cyclophosphamide Sponsors: H. Lee Moffitt Cancer Center and Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
First In Human Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device
Conditions: Prostate; Cancer Interventions: Device: TheraSphere PCa Sponsors: Boston Scientific Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
Conditions: mCRPC (Metastatic Castration-resistant Prostate Cancer); Genital Diseases, Male; Urogenital Diseases, Male; Prostatic Disease; Prostatic Neoplasms, Castration-Resistant; Prostate Cancer Interventions: Drug: Gedatolisib; Drug: Darolutamide Sponsors: Celcuity Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
